Zimbabwe authorizes licence to first medical cannabis company, but drug remains controversial


Although cannabis continues to be referred to as a “dangerous drug” in Zimbabwe legislation, it is estimated that the cannabis market could be worth over USD$7 billion by 2023
Zimbabwe has loosened its regulations surrounding the growing of medical cannabis, aka Mbanje or dagga. But the move is not without controversy and reveals the country’s complicated relationship with the drug. Zimbabwe recently authorized licenses to grow cannabis for medical or research purposes.

Ga naar Bron